PATRICK EYE: Open Payments
NPI 1497768337 · MARMORA, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 29 payments from 11 companies in 2025. Trend: 2023 $252 · 2024 $348 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $155 |
| Novo Nordisk Inc | 9 | $137 |
| Lilly USA, LLC | 4 | $68 |
| Medtronic, Inc. | 1 | $53 |
| PFIZER INC. | 2 | $32 |
| Exact Sciences Corporation | 1 | $26 |
| Astellas Pharma US Inc | 1 | $23 |
| Lundbeck LLC | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
Products named: FARXIGA, Ozempic, MOUNJARO, CLOSUREFAST, BREZTRI, Rybelsus, PREVNAR 20, Cologuard Collection Kit.
Industry payments across NJ — which companies pay providers there.
